New Member Announcement
HKAPI is pleased to announce its new associate members Avalon SteriTech, Fosun International Limited and ZP Therapeutics, which have newly joined our association in the first quarter of 2021.
Avalon SteriTech, founded in 2013, is Hong Kong homegrown biomedical group with major business areas in developing next-generation healthcare solutions including sterilization, disinfection and cleaning technology. Among the company’s anchor partners and clients is MTRC in Hong Kong with which Avalon SteriTech has co-developed disinfection solutions for mass transportation and public spaces to include VHP robots for daily cleaning.
Avalon SteriTech was co-founded by Avalon Biomedical (Avalon TeriTech’s parent company) chairman Dr. Manson Fok, Dean of the Faculty of Medicine at Macau University of Science and Technology, and CTO of Avalon Biomedical Dr. Johnson Lau, Honorary Professor of the University of Hong Kong and Adjunct Professor of the Hong Kong Polytechnic University.
Founded in 1992, Fosun International engaged in pharmaceutical research and development, medical devices and diagnosis, medicine distribution, medical services, maternal and child supplies, care services for the elderly and health consumer goods. Its Health Ecosystem segment includes research and development, manufacture, sale, and trading of pharmaceutical and health products and providing medical services and health management. On 2007 July 16, Fosun International (00656.HK) was listed on the main board of the Hong Kong Stock Exchange.
ZP Therapeutics is a newly rebranded Commercial Solutions division in Zuellig Pharma. Launched in 2020, ZP Therapeutics committed to elevating the standard of healthcare and Asia and making healthcare more accessible. It aims to deepen their therapeutic area focus on cardiovascular disease, infectious disease, women’s health, specialty care, consumer healthcare and medical device by accelerating growth and providing patient-centric, innovative commercial solutions.